Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis

BMJ Open. 2019 Dec 15;9(12):e028638. doi: 10.1136/bmjopen-2018-028638.

Abstract

Objective: To examine the effect of HLP, defined as having a pre-existing or a new in-hospital diagnosis based on low density lipoprotein cholesterol (LDL-C) level ≥100 mg/dL during index hospitalisation or within the preceding 6 months, on all-cause mortality after hospitalisation for acute myocardial infarction (AMI) or acute decompensated heart failure (ADHF) and to determine whether HLP modifies mortality associations of other competing comorbidities. A systematic review and meta-analysis to place the current findings in the context of published literature.

Design: Retrospective study, 1:1 propensity-score matching cohorts; a meta-analysis.

Setting: Large academic centre, 1996-2015.

Participants: Hospitalised patients with AMI or ADHF.

Main outcomes and measures: All-cause mortality and meta-analysis of relative risks (RR).

Results: Unmatched cohorts: 13 680 patients with AMI (age (mean) 68.5 ± (SD) 13.7 years; 7894 (58%) with HLP) and 9717 patients with ADHF (age, 73.1±13.7 years; 3668 (38%) with HLP). In matched cohorts, the mortality was lower in AMI patients (n=4348 pairs) with HLP versus no HLP, 5.9 versus 8.6/100 person-years of follow-up, respectively (HR 0.76, 95% CI 0.72 to 0.80). A similar mortality reduction occurred in matched ADHF patients (n=2879 pairs) with or without HLP (12.4 vs 16.3 deaths/100 person-years; HR 0.80, 95% CI 0.75 to 0.86). HRs showed modest reductions when HLP occurred concurrently with other comorbidities. Meta-analyses of nine observational studies showed that HLP was associated with a lower mortality at ≥2 years after incident AMI or ADHF (AMI: RR 0.72, 95% CI 0.69 to 0.76; heart failure (HF): RR 0.67, 95% CI 0.55 to 0.81).

Conclusions: Among matched AMI and ADHF cohorts, concurrent HLP, compared with no HLP, was associated with a lower mortality and attenuation of mortality associations with other competing comorbidities. These findings were supported by a systematic review and meta-analysis.

Keywords: acute myocardial infarction; heart failure; hyperlipidemia; mortality.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Cause of Death
  • Cholesterol, LDL / blood
  • Heart Failure / complications*
  • Heart Failure / mortality*
  • Humans
  • Hyperlipidemias / complications*
  • Hyperlipidemias / diagnosis
  • Kaplan-Meier Estimate
  • Myocardial Infarction / complications*
  • Myocardial Infarction / mortality*
  • Propensity Score
  • Proportional Hazards Models
  • Retrospective Studies

Substances

  • Cholesterol, LDL